Pharmacologic interventions for mydriasis in cataract surgery

Fasika A. Woreta; Tahreem A. Mir; Henry Jampel

doi:10.1002/14651858.CD012830

Pharmacologic interventions for mydriasis in cataract surgery

Fasika A. Woreta
, Tahreem A. Mir
, Henry Jampel

School of Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: Primary objectives: To evaluate the effectiveness of various methods of pupillary dilation among people who underwent phacoemulsification for cataract extraction. Comparisons of interest include topical mydriatics versus intracameral mydriatics, topical mydriatics versus depot delivery systems, and intracameral mydriatics versus depot delivery systems. Secondary objectives: To assess and compare the incidence of intra- and postoperative cardiovascular and ocular complications associated with the use of these methods of pupillary dilation. We will also compare the cost-effectiveness of these methods during routine cataract surgery.

Original language	English (US)
Article number	CD012830
Journal	Cochrane Database of Systematic Reviews
Volume	2017
Issue number	10
DOIs	https://doi.org/10.1002/14651858.CD012830
State	Published - Oct 13 2017

ASJC Scopus subject areas

Pharmacology (medical)

Access to Document

10.1002/14651858.CD012830

Cite this

@article{fdcbba6cfa0e4affb1f56ead6a8be386,

title = "Pharmacologic interventions for mydriasis in cataract surgery",

abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: Primary objectives: To evaluate the effectiveness of various methods of pupillary dilation among people who underwent phacoemulsification for cataract extraction. Comparisons of interest include topical mydriatics versus intracameral mydriatics, topical mydriatics versus depot delivery systems, and intracameral mydriatics versus depot delivery systems. Secondary objectives: To assess and compare the incidence of intra- and postoperative cardiovascular and ocular complications associated with the use of these methods of pupillary dilation. We will also compare the cost-effectiveness of these methods during routine cataract surgery.",

author = "Woreta, \{Fasika A.\} and Mir, \{Tahreem A.\} and Henry Jampel",

note = "Funding Information: • Cochrane Eyes and Vision US Project, supported by cooperative agreement 1 U01 EY020522, National Eye Institute, National Institutes of Health, USA. • National Institute for Health Research (NIHR), UK. • Richard Wormald, Co-ordinating Editor for Cochrane Eyes and Vision (CEV) acknowledges financial support for his CEV research sessions from the Department of Health through the award made by the National Institute for Health Research to Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology. • This protocol was supported by the NIHR, via Cochrane Infrastructure funding to the CEV UK editorial base. Publisher Copyright: {\textcopyright} 2017 The Cochrane Collaboration. Published by John Wiley \& Sons, Ltd.",

year = "2017",

month = oct,

day = "13",

doi = "10.1002/14651858.CD012830",

language = "English (US)",

volume = "2017",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

number = "10",

}

TY - JOUR

T1 - Pharmacologic interventions for mydriasis in cataract surgery

AU - Woreta, Fasika A.

AU - Mir, Tahreem A.

AU - Jampel, Henry

N1 - Funding Information: • Cochrane Eyes and Vision US Project, supported by cooperative agreement 1 U01 EY020522, National Eye Institute, National Institutes of Health, USA. • National Institute for Health Research (NIHR), UK. • Richard Wormald, Co-ordinating Editor for Cochrane Eyes and Vision (CEV) acknowledges financial support for his CEV research sessions from the Department of Health through the award made by the National Institute for Health Research to Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology. • This protocol was supported by the NIHR, via Cochrane Infrastructure funding to the CEV UK editorial base. Publisher Copyright: © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

PY - 2017/10/13

Y1 - 2017/10/13

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: Primary objectives: To evaluate the effectiveness of various methods of pupillary dilation among people who underwent phacoemulsification for cataract extraction. Comparisons of interest include topical mydriatics versus intracameral mydriatics, topical mydriatics versus depot delivery systems, and intracameral mydriatics versus depot delivery systems. Secondary objectives: To assess and compare the incidence of intra- and postoperative cardiovascular and ocular complications associated with the use of these methods of pupillary dilation. We will also compare the cost-effectiveness of these methods during routine cataract surgery.

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: Primary objectives: To evaluate the effectiveness of various methods of pupillary dilation among people who underwent phacoemulsification for cataract extraction. Comparisons of interest include topical mydriatics versus intracameral mydriatics, topical mydriatics versus depot delivery systems, and intracameral mydriatics versus depot delivery systems. Secondary objectives: To assess and compare the incidence of intra- and postoperative cardiovascular and ocular complications associated with the use of these methods of pupillary dilation. We will also compare the cost-effectiveness of these methods during routine cataract surgery.

UR - https://www.scopus.com/pages/publications/85030973937

UR - https://www.scopus.com/pages/publications/85030973937#tab=citedBy

U2 - 10.1002/14651858.CD012830

DO - 10.1002/14651858.CD012830

M3 - Article

AN - SCOPUS:85030973937

SN - 1465-1858

VL - 2017

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 10

M1 - CD012830

ER -

Pharmacologic interventions for mydriasis in cataract surgery

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this